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ABSTRACT
Objective: The present abstract makes the use of multivariate calibration technique for the quantification of ivermectin in pharmaceutical dosage 
form.
Methods: Multivariate calibration technique is based on the use of linear regression equations, by correlating the relation between concentration 
and absorbance at seven different selected wavelengths. The λmax of ivermectin was found to be 245 nm. The results were treated statistically. This 
statistical approach gives optimum results by eliminating the fluctuations arising from the instrumental or experimental conditions.
Results: The developed method was validated as per the ICH guidelines and was found to be simple, linear, accurate, precise, and reproducible. 
The method was found to be linear over a concentration range of 5–15 µg/mL with a correlation coefficient (r2) value of about 0.9998. The limit 
of detection and quantification were found to be 0.029 and 0.087 µg/mL, respectively. The percentage relative standard deviation for intraday and 
interday precision was found to be in the range of 0.473–1.373 and 0.301–1.617, respectively. The percentage recovery was found within the range 
of 97.60–101.80% w/w.
Conclusion: The results evidence that a simple, linear, precise, accurate, sensitive, and reproducible multivariate calibration technique has been 
developed and validated for the quantification of ivermectin in bulk and pharmaceutical formulation.
Keywords: Ivermectin, ICH guidelines, Multivariate calibration technique, Pharmaceutical formulation, Validation.
INTRODUCTION
Ivermectin (Fig. 1) (N-[3-(3-cyanopyrazolo [1,-5-a] pyrimidin-7-yl) 
phenyl]-N-ethylacetamide) is a pyrazolopyrimidine derivative 
that acts as an effective hypnotic and selectively binds to the α 1 
benzodiazepine receptors [1]. It is being used for treating certain 
worm infections, onchocerciasis (river blindness), and some types 
of diarrhea (strongyloidiasis). It paralyzes and kills the offspring 
of adult worms which slowdowns the rate of reproduction of the 
adult worm that results in fewer worms in skin, eyes, and blood [2]. 
Its molecular formula is C17H15N5O and has a molecular weight of 
about 305.33 g/mol [3]. The drug is official in Indian, British, and 
the United States Pharmacopoeia. The literature survey reveals on 
the reported methods for the determination of ivermectin which 
includes spectrophotometry [4], capillary electrophoresis [5], high-
performance thin-layer chromatography [6], high- performance liquid 
chromatography (LC) [7], LC–tandem mass spectrometry (MS) [8], and 
a gas chromatography–MS [9] either in pharmaceutical formulations or 
in biological fluids.
Spectrophotometric methods due to their inherent rapidity, simplicity 
of procedures, and low cost of the technique are employed as the 
favorable method in most of the laboratories [10,11]. The opted method 
is based on the direct determination of ivermectin with high range of 
accuracy and precision. The method is simple, economical and can be 
applied to estimate ivermectin in bulk drug and pharmaceuticals. The 
proposed method characterizes the use of UV spectral multivariate 
calibration technique employing simple mathematical contents for the 
estimation of ivermectin in pharmaceutical dosage form.
Multivariate calibration represents the conversion of single common 
species analysis from one dependent variable to “m” dependent 
variables, for example, wavelengths or sensors, which can be 
simultaneously included in the calibration model [12].
Under optimized conditions, the functional statistical method gives 
appreciable resolving power, sensitivity, rapidity and low cost for 
the quantitative analysis, quality control, and routine analysis of the 
investing compounds [13].
The absorbance of an analyte (X) is measured at five wavelengths set 
(λ=226, 228, 230, 232, and 234 nm), the following equation can be 
written for individual selected wavelength.
Aλ226 = aXCx+k1 (1)
Aλ228 = bXCx+k2 (2)
Aλ230 = cXCx+k3 (3)
Aλ232 = dXCx+k4 (4)
Aλ234= eXCx+k5 (5)
Where, Aλ represents the absorbance of the analyte; a, b, c, d, and e are 
the slopes of the linear regression functions of the analyte; k1, k2, k3, k4, 
and k5 are the intercepts of the linear regression functions at the five 
selected bandwidth and Cx represents the concentration of the analyte. 
The above five equation systems (1-5) can be summarized as follows:
AT = axCx+bxCx+cxCx+dxCx+exCx+KT (6)
Which can be further simplified to
AT = Cx (a+b+c+d+e)+KT (7)
© 2019 The Authors. Published by Innovare Academic Sciences Pvt Ltd. This is an open access article under the CC BY license (http://creativecommons. 
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Where, AT and KT represent the sum of the absorbance obtained and 
the sum of intercepts of regression equations at five wavelength set, 
respectively. The concentration of the analyte X in a solution can be 
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• The reference standard of ivermectin was obtained as gift sample 
from Pondchy Pharmaceuticals, Puducherry. The marketed tablet 
formulation used was rapimec (label claim - 10 mg of Ivermectin), 
from the same pharmaceutical company.
Solubility
Instrumentation





Ivermectin was freely soluble in ethanol which was used as the solvent 
to solubilize the standard drug and the sample as well.
Preparation of standard stock solution
The standard stock solution of ivermectin was prepared by dissolving 
10 mg of the drug in 10 mL of the solvent to obtain a concentration of 
1 mg/mL. The above solution was further diluted to get concentrations 
in the range of 5–15 µg/mL.
Determination of λmax
The stock solution of ivermectin was diluted with the solvent to get a 
concentration of 10 µg/mL. This solution was scanned in the UV region 
from 400 to 200 nm. The λmax was found to be 245 nm (Fig. 2).
Preparation of sample solution
A total of 20 tablets of ivermectin were weighed and the contents 
were transferred into a mortar, powdered, and mixed well. A weight 
equivalent to 10 mg of ivermectin was weighed and dissolved in 5 mL 
of ethanol. The above solution was sonicated for 15 min and finally 
made up to the mark with ethanol, filtered, and diluted for further 
analysis.
Method validation
The developed method was validated as per the ICH Q2 R1 guidelines 
to check validation parameters such as linearity, sensitivity, precision, 
and accuracy [14].
Linearity
Stock solution of ivermectin was diluted with the solvent to get a 
concentration in the range of 5–15 µg/mL. Now, to develop correlation 
and to reduce the instrumental fluctuations, absorbance of the above 
solutions was recorded in several selected wavelengths around the 
λmax of the drug (245 nm), that is, 239, 241, 243, 245, 247, 249, and 
251 nm.
The overlay UV spectra showing linearity at the λmax (245 nm) were 
represented in Fig. 3. The absorbance values of the five different 
selected concentrations were recorded and represented in Table 1. 
Linearity data showing system suitability parameters at the selected 
wavelengths are shown in Table 2.
The calibrations graphs and the residual plots at the seven selected 
wavelengths were represented in Figs. 4-10 and Figs. 11-17, respectively.
Precision
Intraday and interday precision was performed by measuring the 
absorbance of the solutions of concentration 5, 10, and 15 µg/mL at 
all the seven selected wavelengths. Each concentration was scanned 
3 times a day (intraday precision) and for three different days (interday 
precision). The absorbance values recorded at the selected wavelengths 
for intraday and interday precision were provided in Tables 3 and 4. 
The SD and percentage relative standard deviation (RSD) values 
obtained at different wavelengths were calculated and represented in 
Tables 5 and 6. The overlay UV spectra for intra- and inter-day precision 
are shown in Figs. 18 and 19.
Assay
The absorbance of the extracted sample solution was recorded at 
245 nm and the amount of drug present in the formulation was 
estimated (Table 7).
Accuracy (recovery studies)
The accuracy of the developed method was evaluated by standard 
addition method at 80%, 100%, and 120% of the selected concentration 
levels. From the prepared stock solutions of standard and sample, 
0.4 mL of standard solution was pipetted into three different volumetric 
flasks and 0.1, 0.6, and 1.1 mL of the sample solution were added to the 
Fig. 1: Chemical structure of ivermectin
Fig. 2: UV spectrum of ivermectin
• Very freely soluble in methanol, ethanol, acetone, ethyl acetate, and 
acetonitrile.
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above volumetric flasks and the volume was made up to 10 mL with 
ethanol. The percentage recovery values were calculated. The results 
representing recovery studies are shown in Fig. 20 and provided in 
Table 8.
RESULTS AND DISCUSSION
The λmax of ivermectin was found to be 245 nm employing ethanol as 
the solvent (Fig. 2).
Linearity
The UV spectra showing linearity at 245 nm are represented in Fig. 3. 
The linearity for different prepared concentration of 5–15 µg/mL was 
Table 1: Multivariate UV calibration at seven selected wavelengths
Concentration (µg/mL) Absorbance (nm)
239 241 243 245 247 249 251
5 0.158 0.160 0.167 0.171 0.158 0.135 0.119
7.5 0.240 0.243 0.254 0.261 0.242 0.207 0.181
10 0.319 0.324 0.340 0.349 0.324 0.276 0.240
12.5 0.402 0.408 0.426 0.437 0.405 0.346 0.301
15 0.480 0.487 0.510 0.524 0.486 0.415 0.361
Table 2: Linearity data showing system suitability parameters at the selected wavelengths
Wave length (nm) Regression equation Slope Intercept % intercept r2 LOD (µg/mL) LOQ (µg/mL)
239 y=0.0322x−0.0026 0.0322 0.0026 0.26 0.9999 0.039 0.117
241 y=0.0328x−0.0032 0.0328 0.0032 0.32 0.9999 0.105 0.319
243 y=0.0339x−0.0028 0.0339 0.0028 0.28 0.9990 0.068 0.206
245 y=0.0353x−0.0064 0.0353 0.0064 0.64 0.9991 0.029 0.087
247 y=0.0328x−0.0046 0.0328 0.0046 0.46 0.9999 0.019 0.058
249 y=0.028x−0.0026 0.028 0.0026 0.26 0.9993 0.036 0.110
251 y=0.0243x−0.003 0.0243 0.003 0.3 0.9999 0.034 0.104
Fig. 3: Overlay UV spectrum showing linearity of ivermectin
Fig. 4: Calibration graph at 239 nm
Fig. 5: Calibration graph at 241 nm
Fig. 6: Calibration graph at 243 nm
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recorded at the selected wavelengths of about 239, 241, 243, 245, 247, 
249, and 251 nm. The observed results were tabulated in Table 1.
All the calibration curves were found to be linear over the selected 
concentration range of about 5–15 µg/mL. The linear regression 
analysis data of the constructed calibration plots showed good linear 
relation with a correlation coefficient (r2) > 0.998. The calibration 
Fig. 7: Calibration graph at 245 nm
Fig. 8: Calibration graph at 247 nm
Table 4: Absorbance values for interday precision
Concentration µg/mL) Number of repetitions Absorbance (nm)
239 241 243 245 247 249 251
5 1 0.141 0.142 0.150 0.157 0.141 0.120 0.101
2 0.143 0.142 0.152 0.153 0.143 0.122 0.101
3 0.140 0.141 0.151 0.153 0.142 0.121 0.102
10 1 0.300 0.303 0.332 0.331 0.310 0.255 0.220
2 0.305 0.301 0.333 0.334 0.315 0.261 0.222
3 0.300 0.302 0.331 0.340 0.310 0.255 0.221
15 1 0.460 0.465 0.490 0.500 0.460 0.392 0.343
2 0.472 0.462 0.500 0.515 0.475 0.403 0.352
3 0.460 0.451 0.492 0.509 0.466 0.395 0.344
Table 5: Intraday precision
Concentration (µg/mL) Description 239 nm 241 nm 243 nm 245 nm 247 nm 249 nm 251 nm
5 Mean 0.152 0.153 0.153 0.166 0.152 0.122 0.112
SD 0.002 0.001 0.002 0.002 0.002 0.001 0.001
% RSD 1.373 0.753 1.001 0.918 1.373 0.949 0.893
10 Mean 0.316 0.323 0.336 0.343 0.317 0.269 0.233
SD 0.003 0.002 0.004 0.004 0.004 0.003 0.003
% RSD 1.018 0.473 1.073 1.105 1.137 0.937 1.136
15 Mean 0.467 0.474 0.497 0.510 0.469 0.398 0.347
SD 0.005 0.006 0.006 0.005 0.005 0.005 0.004
% RSD 1.113 1.163 1.161 0.988 1.108 1.161 1.256
Table 3: Absorbance values for intraday precision
Concentration (µg/mL) Number of repetitions Absorbance (nm)
239 241 243 245 247 249 251
5 1 0.151 0.154 0.151 0.165 0.151 0.121 0.112
2 0.15 0.152 0.153 0.166 0.15 0.123 0.111
3 0.154 0.154 0.154 0.168 0.154 0.121 0.113
10 1 0.317 0.324 0.337 0.341 0.318 0.269 0.232
2 0.318 0.323 0.339 0.347 0.32 0.271 0.236
3 0.312 0.321 0.332 0.34 0.313 0.266 0.231
15 1 0.464 0.47 0.494 0.505 0.466 0.395 0.345
2 0.473 0.48 0.504 0.515 0.475 0.403 0.352
3 0.464 0.471 0.494 0.509 0.466 0.395 0.344
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Table 6: Interday precision
Concentration (µg/mL) Description 239 nm 241 nm 243 nm 245 nm 247 nm 249 nm 251 nm
5 Mean 0.141 0.142 0.151 0.154 0.142 0.121 0.101
SD 0.002 0.001 0.001 0.002 0.001 0.001 0.001
% RSD 1.081 0.408 0.662 1.496 0.704 0.826 0.570
10 Mean 0.302 0.302 0.332 0.335 0.312 0.257 0.221
SD 0.003 0.001 0.001 0.005 0.003 0.003 0.001
% RSD 0.957 0.331 0.301 1.368 0.926 1.348 0.452
15 Mean 0.464 0.459 0.494 0.508 0.467 0.397 0.346
SD 0.007 0.007 0.005 0.008 0.008 0.006 0.005
% RSD 1.493 1.605 1.071 1.486 1.617 1.434 1.424
Table 7: Assay of ivermectin







Fig. 9: Calibration graph at 249 nm
Fig. 10: Calibration graph at 251 nm
Fig. 11: Residual plot at 239 nm
Fig. 12: Residual plot at 241 nm
graphs and the system suitability parameters were presented in 
Figs. 4-17 and Table 2, respectively.
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Precision
Intra- and inter-day precision studies were carried out. The percentage 
RSD values for intraday and interday precision were found to lie within 
the range of 0.473–1.373 and 0.301–1.617 which was found well within 
the acceptance criteria of <2% at all the selected wavelengths. The low 
percentage RSD values indicate that the suggested method was precise. 
The results of precision study were represented in Figs. 18-19 and 
tabulated in Tables 3-6.
Fig. 13: Residual plot at 243 nm
Fig. 14: Residual plot at 245 nm
Fig. 15: Residual plot at 247 nm
Fig. 16: Residual plot at 249 nm
Fig. 17: Residual plot at 251 nm
Fig. 18: Overlay UV spectrum showing intraday precision
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Assay
The absorbance of the extracted sample solution was recorded at 
245 nm and the amount of drug present in the formulation was 
estimated. The assay percentage of ivermectin (rapimec tablets) was 
found to be 98.7% w/w. The amount estimated in the formulation was 
found to be 9.87 mg and the percentage RSD value was found to be <2% 
(Table 7).
Recovery
The percentage recovery of the drug by standard addition method was 
calculated and was found to be in the range of 97.60–101.80% w/w, 
which was well within the acceptance limit of 97–103% w/w as per 
the ICH guidelines. Hence, the full-fledged method was found to be 
accurate. The reports of accuracy study were shown in Fig. 20 and 
Table 8.
CONCLUSION
The newly developed spectrophotometric multivariate calibration 
technique was validated by employing various validation parameters as 
per the ICH guidelines and was found to lie within the acceptance limits. 
The method developed in the present study was found to be sensitive, 
accurate, precise, and reproducible for the estimation of ivermectin 
in its tablet formulation. Therefore, a simple and rapid method 
using mathematical contents was developed, which was found more 
predictable than the other spectrophotometric methods and is strongly 
recommended for the routine quality control analysis of ivermectin in 
pharmaceutical formulations.
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239 80 5 4 1 4.98 99.60
100 10 4 6 9.84 98.40
120 15 4 11 14.86 99.07
241 80 5 4 1 4.99 99.80
100 10 4 6 9.85 98.50
120 15 4 11 14.72 98.13
243 80 5 4 1 4.88 97.60
100 10 4 6 10.01 100.10
120 15 4 11 15.07 100.47
245 80 5 4 1 5.09 101.80
100 10 4 6 9.87 98.70
120 15 4 11 14.96 99.73
247 80 5 4 1 4.96 99.20
100 10 4 6 9.88 98.80
120 15 4 11 15.09 100.60
249 80 5 4 1 4.88 97.60
100 10 4 6 9.99 99.90
120 15 4 11 15.07 100.47
251 80 5 4 1 5.03 100.60
100 10 4 6 9.85 98.50
120 15 4 11 14.95 99.67
Fig. 19: Overlay UV spectrum showing interday precision
Fig. 20: Overlay UV spectrum displaying accuracy of ivermectin
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